Sonoma Pharmaceuticals Inc (SNOA) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2026, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Sonoma Pharmaceuticals Inc   (NASDAQ: SNOA)
 

Sonoma Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Sonoma Pharmaceuticals Inc inventory turnover ratio, the Sonoma Pharmaceuticals Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 3.83 in the first quarter 2026, SNOA's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Sonoma Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 95 days, compare to 105 days, in the Mar 31 2026 quarter.

Within Healthcare sector 117 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1221 in the fourth quarter 2026, to 1335.

SNOA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Sonoma Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SNOA Inventory Turnover Ratio (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter
Y / Y Inventory Growth -0.42 % 25.25 % 7.21 % 28.09 % 43.04 %
Y / Y Cost of Sales Growth 50.1 % 51.84 % 17.65 % 57.08 % 22.35 %
Inventory Turnover Ratio (TTM) 3.83 3.46 3.3 3.23 3.03
SNOA's Total Ranking # 1335 # 1221 # 1252 # 1218 # 1340
Average inventory processing period 95 105 110 113 121
Seq. Inventory Growth 3.7 % 25.25 % -19.79 % -4.42 % 30.43 %
Seq. Cost of Sales Growth 13.28 % 25.23 % -22.53 % 36.57 % 14.6 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 49
Healthcare Sector # 118
Overall Market # 1335

Inventory Turnover Ratio Statistics
High Average Low
5.83 2.29 -0.11
(Dec 31 2018)   (Sep 30 2012)



SNOA Company Profile >> Back to SNOA Efficiency Comparisons >> Compare SNOA Inventory Turnover Ratio to its Competitors

Financial Statements
Sonoma Pharmaceuticals Inc 's Inventories $ 4 Millions Visit SNOA's Balance sheet
Sonoma Pharmaceuticals Inc 's Cost of Revenues TTM $ 13 Millions Visit SNOA's Income Statement
What are SNOA's Sales? Visit SNOA's Sales by Segment

Other Inventory Turnover Ratios
Sonoma Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SNOA's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SNOA's Competitors
Inventory Turnover Ratio for SNOA's Suppliers
Inventory Turnover Ratio for SNOA's Customers

You may also want to know
SNOA's Sales Growth Rates SNOA's Pe Price to earnings ratio SNOA's Receivables Turnover Ratio SNOA's Stock Quote
SNOA's Net Income Growth Rates SNOA's Ps Price to Sales ratio SNOA's Sales per Employee SNOA's Asset Turnover Ratio
SNOA's Net Margin SNOA's Pb Price to Book ratio SNOA's Financial Strength Ratios SNOA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   7.43 $ 13.506  Millions$ 2  Millions
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Twist Bioscience Corporation  6.62 $ 207.413  Millions$ 31  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Align Technology inc   6.00 $ 1,321.762  Millions$ 220  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions

Date modified: 2026-09-05T15:31:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.